Study: Much of Mental Health Panel Has Ties to Rx Industry

About 69% of the members of a panel revising the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders have current or past financial ties to the pharmaceutical industry, according to a new report published in the journal PLoS Medicine. Lisa Cosgrove of the University of Massachusetts-Boston and Sheldon Krimsky of Tufts University School of Medicine -- the report's authors -- found that 16 of the approximately 140 members of the panel are California-based physicians and researchers.

to share your thoughts on this article.